You say,,,,There is a reason why Healthlinx has only had $6k of sales in the last 12 months. Well what about SpringTree.....30th November 2009, Melbourne: HealthLinx Limited (ASX:HTX) will receive new investment funding of up to $1.1 million via a share placement through Stonebridge Securities Limited. The funding will support the commercial roll out of HealthLinx ovarian cancer test OvPlexTM over the next 12 months and follows $7.2m funding from New York based SpringTree and $750k Victorian government grant in past two months.
Add to My Watchlist
What is My Watchlist?